title: Impact of genetic predisposition of de novo uveitis with etanercept in ankylosing spondylitis.
authors.affiliation: Rheumatology Department, University Hospital of Saint-Etienne, Saint-Etienne, France.
authors.forename: Martin
authors.initials: M
authors.lastname: Killian
authors.affiliation: Laboratory of Genetics Saint-Etienne, University Hospital of Saint-Etienne, Saint-Etienne, France.
authors.forename: Renaud
authors.initials: R
authors.lastname: Touraine
authors.affiliation: Rheumatology Department, University Hospital of Saint-Etienne, Saint-Etienne, France.
authors.forename: Adamah
authors.initials: A
authors.lastname: Amouzougan
authors.affiliation: Rheumatology Department, University Hospital of Saint-Etienne, Saint-Etienne, France INSERM U1059/LBTO, Université de Lyon - Université Jean Monnet, Saint-Etienne, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Thomas
authors.affiliation: Rheumatology Department, University Hospital of Saint-Etienne, Saint-Etienne, France INSERM U1059/LBTO, Université de Lyon - Université Jean Monnet, Saint-Etienne, France.
authors.forename: Hubert
authors.initials: H
authors.lastname: Marotte
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008297:Male; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014605:Uveitis / Q000517:prevention & control*
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor
keywords: Ankylosing Spondylitis; Anti-TNF; Gene Polymorphism